HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of disseminated carcinoma of the breast by metenolone enanthate.

Abstract
Forty-three patients with disseminated or inoperable carcinoma of the breast were treated with Metenolone Enanthate (Primobolan Depot) with doses of 400 to 1 200 mg/week for at least 3 months. Objective remissions lasting longer than 3 months occurred in 8 out of 41 evaluable patients. Soft tissue metastases responsed best. Liver and brain metastases were unaffected. The therapeutic efficiency of Primobolan Depot is comparable to that of testosterone propionate but the agent is less virilising.
AuthorsG Notter
JournalActa radiologica: therapy, physics, biology (Acta Radiol Ther Phys Biol) Vol. 14 Issue 6 Pg. 545-51 (Dec 1975) ISSN: 0567-8064 [Print] Sweden
PMID1224996 (Publication Type: Journal Article)
Chemical References
  • Methenolone
Topics
  • Aged
  • Breast Neoplasms (drug therapy)
  • Female
  • Hirsutism (chemically induced)
  • Hoarseness (chemically induced)
  • Humans
  • Libido (drug effects)
  • Lymphatic Metastasis
  • Methenolone (adverse effects, therapeutic use)
  • Middle Aged
  • Neoplasm Metastasis
  • Remission, Spontaneous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: